CF PharmTech (02652.HK) Reports Share Repurchase and Issued Shares Update

Bulletin Express

02/20

CF PharmTech (02652.HK) disclosed that on 20 February 2026, it repurchased 8,000 shares on the Hong Kong Stock Exchange at an average price of HKD 36.28 per share. The highest repurchase price was HKD 36.50, the lowest was HKD 36.08, and the total consideration amounted to HKD 290,260.00. The repurchased shares were placed in treasury, bringing the total treasury shares to 0.36 million.

Following the transaction, the number of issued shares excluding treasury shares decreased to 301.86 million, while the total issued share count remained at 302.22 million. The repurchase falls under a mandate dated 16 December 2025, which authorizes up to 30.22 million shares. The company is subject to a moratorium until 22 March 2026 regarding the issuance of new shares or the sale of any treasury shares.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1144671424"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1144671424\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1144671424?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-20 18:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144671424","market":"hk","top_or_hot":-1,"title":"CF PharmTech (02652.HK) Reports Share Repurchase and Issued Shares Update","media":"Bulletin Express","content":"<p>CF PharmTech (02652.HK) disclosed that on 20 February 2026, it repurchased 8,000 shares on the Hong Kong Stock Exchange at an average price of HKD 36.28 per share. The highest repurchase price was HKD 36.50, the lowest was HKD 36.08, and the total consideration amounted to HKD 290,260.00. The repurchased shares were placed in treasury, bringing the total treasury shares to 0.36 million.</p>\n<p>Following the transaction, the number of issued shares excluding treasury shares decreased to 301.86 million, while the total issued share count remained at 302.22 million. The repurchase falls under a mandate dated 16 December 2025, which authorizes up to 30.22 million shares. The company is subject to a moratorium until 22 March 2026 regarding the issuance of new shares or the sale of any treasury shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PharmTech (02652.HK) Reports Share Repurchase and Issued Shares Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PharmTech (02652.HK) Reports Share Repurchase and Issued Shares Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-20 18:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CF PharmTech (02652.HK) disclosed that on 20 February 2026, it repurchased 8,000 shares on the Hong Kong Stock Exchange at an average price of HKD 36.28 per share. The highest repurchase price was HKD 36.50, the lowest was HKD 36.08, and the total consideration amounted to HKD 290,260.00. The repurchased shares were placed in treasury, bringing the total treasury shares to 0.36 million.</p>\n<p>Following the transaction, the number of issued shares excluding treasury shares decreased to 301.86 million, while the total issued share count remained at 302.22 million. The repurchase falls under a mandate dated 16 December 2025, which authorizes up to 30.22 million shares. The company is subject to a moratorium until 22 March 2026 regarding the issuance of new shares or the sale of any treasury shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02652","symbol_name":"长风药业","start_time":0,"source_url":"","article_id":"1144671424","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144671424","pubTimestamp":1771582984,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CF PharmTech (02652.HK) disclosed that on 20 February 2026, it repurchased 8,000 shares on the Hong Kong Stock Exchange at an average price of HKD 36.28 per share. The highest repurchase price was...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02652":"长风药业"},"translate_title":"CF PharmTech(02652.HK)报告股份购回及已发行股份更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":1},"content_text":"CF PharmTech (02652.HK) disclosed that on 20 February 2026, it repurchased 8,000 shares on the Hong Kong Stock Exchange at an average price of HKD 36.28 per share. The highest repurchase price was HKD 36.50, the lowest was HKD 36.08, and the total consideration amounted to HKD 290,260.00. The repurchased shares were placed in treasury, bringing the total treasury shares to 0.36 million.\nFollowing the transaction, the number of issued shares excluding treasury shares decreased to 301.86 million, while the total issued share count remained at 302.22 million. The repurchase falls under a mandate dated 16 December 2025, which authorizes up to 30.22 million shares. The company is subject to a moratorium until 22 March 2026 regarding the issuance of new shares or the sale of any treasury shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}